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doi:10.1016/j.ejvs.2011.04.010Abstract Objective: A polymorphism in the angiotensin-converting-enzyme gene (ACE I/D)
has been associated with abdominal aortic aneurysm and a link between aortic aneurysm
and aortic stiffness has been suggested. This study aimed to explore the links between ACE
I/D polymorphism, circulating ACE and abdominal aortic wall integrity as reflected by
abdominal aortic wall stiffness.
Material: A total of 212 men and 194 women, aged 70e88 years, were studied.
Methods: Mechanical properties of the abdominal aorta were determined using the Wall Track
System, ACE genotype using the polymerase chain reaction (PCR) and circulating ACE level by
enzyme-linked immunosorbent assay (ELISA).
Results: In men, pulsatile diameter change differed between genotypes (II 0.70, ID 0.55 and DD
0.60 mm, PZ 0.048), whereas a tendency was seen for distensibility coefficient (DC) (II 10.38,
ID 7.68 and ID 8.79, PZ 0.058). Using a dominant model (II vs. ID/DD), men carrying the ACE D
allele had lower pulsatile diameter change (P Z 0.014) and DC (P Z 0.017) than II carriers.
Multiple regression analyses showed additional associations between the D allele and increased
stiffness b, and reduced compliance coefficient.
Conclusion: Men carrying the ACE D allele have stiffer abdominal aortas compared with II
carriers. Deranged abdominal aortic stiffness indicates impaired vessel wall integrity, which,
along with other local predisposing factors, may be important in aneurysmal disease.
ª 2011 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved., Division of Cardiovascular Medicine, Department of Medical and Health Sciences, Faculty of Health
85 Linko¨ping, Sweden. Tel.: þ46 (0)101 037 476; fax: þ46 (0) 131 491 06.
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310 L.U. Ljungberg et al.A genetic polymorphism in the angiotensin-converting Blood samples were taken after an overnight fast andenzyme (ACE) gene (ACE I/D polymorphism) has previously
been associated with increased cardiovascular risk, with
carriers of the ACE D allele being more susceptible.1,2 In
addition, this polymorphism has been associated with
abdominal aortic aneurysm (AAA),35 although this associ-
ation has been questioned.6 The abdominal aorta is of
particular interest, as age- and gender-related changes are
more pronounced at this site than in other arteries7 and as
the abdominal aorta is particularly prone to aneurysm
formation.8 The mechanical properties of the abdominal
aorta are measures of aortic wall integrity. Impaired wall
integrity might, along with other local haemodynamic and
inflammatory processes, predispose to aneurysm forma-
tion. The aim of the study was to investigate the association
between ACE I/D polymorphism, circulating ACE and the
mechanical properties of the abdominal aorta in elderly
men and women.
Materials and Methods
Study population
Subjects were recruited from an ongoing longitudinal study
of elderly people from a rural community in southeast
Sweden.
All inhabitants aged 65e82 years were invited to
participate in the original study.9 A total of 876 individuals,
of the 1130 originally invited, agreed to participate.9 During
a follow-up study, which was carried out between 2003 and
2005, we had the opportunity to perform a cross-sectional
study in this population. A total of 123 individuals died
before the follow-up study started. As many as 452 of the
remaining study population agreed to take part in the
present study, of whom 23 subjects were excluded due to
irregular heart rate (e.g., atrial fibrillation) with variable
pressure pulses in the arteries, difficulties in obtaining
a blood sample or hepatitis infection. In the remaining 429
subjects, the abdominal aorta was examined using ultra-
sound. Twenty-three of these were excluded due to low
quality of the ultrasonic measurements, resulting in a final
study population of 406 subjects (212 men and 194 women)
aged 70e88 years.
Subjects were asked to refrain from tobacco, coffee and
tea for at least 4 h before the examination. All participants
had a physical examination and were asked about cardio-
vascular risk factors, cardiovascular disease and medica-
tions. Individuals with a previous diagnosis of hypertension,
or with a blood pressure 140/90 mmHg were defined as
hypertensive. Diabetes mellitus was defined as a previous
diagnosis of diabetes or a fasting plasma glucose
7 mmol l1. Ischaemic heart disease (IHD) was defined as
history of angina pectoris or electrocardiograph (ECG)-
verified myocardial infarction. Individuals who stated that
they smoked were classified as smokers. A diameter
30 mm of the abdominal aorta, a localised abdominal
aortic dilatation or previous surgical repair was defined as
AAA. All participants gave their written informed consent.
The study was approved by the Regional Ethical Review
board in Linko¨ping, Sweden, and was conducted in accor-
dance with principles stated in the Declaration of Helsinki.collected in pre-chilled plastic Vacutainer tubes (Terumo
EDTA K-3). Plasma was prepared by centrifugation at 3000 g
for 10 min at 4 C. Blood and plasma were stored at 70 C
pending analysis. Fasting glucose, low-density lipoprotein
(LDL) and high-density lipoprotein (HDL) were measured in
plasma. Height and weight were recorded and used for
calculation of body mass index (BMI) and body surface area
(BSA).
Blood pressure measurements
Brachial blood pressure was measured with subjects in the
supine position using an oscillometric technique (Dinamap
model PRO 200 Monitor, Critikon, Tampa, FL, USA) after at
least 15 min of rest. Systolic, diastolic and mean arterial
pressures (MAP) were measured, and pulse pressure was
calculated as: systolic pressureediastolic pressure.
Measurement of intimaemedia thickness and
lumen diameter in the abdominal aorta
The abdominal aorta was examined approximately 3e4 cm
proximal to the aortic bifurcation. The Wall Track System
(WTS2; Pie Medical, Maastricht, the Netherlands) was used
to determine lumen diameter, pulsatile diameter changes
during the cardiac cycle and intimaemedia thickness (IMT),
as described previously.10,11 An ultrasound scanner (Esaote
AU5; Esaote Biomedica, Florence, Italy) equipped with
a 7.5-MHz linear transducer or a 7.3-MHz curved transducer
was used. All measurements were carried out by two
experienced ultrasonographers on a single occasion, with
subjects in the supine position, immediately following
brachial blood pressure measurements. IMT of the posterior
wall was measured in diastole. Diastolic and systolic lumen
diameter and pulsatile diameter change were determined
between the posterior and the anterior wall. Mean values
from three successive recordings were used.
Calculations
The compliance coefficient (CC) and the distensibility
coefficient (DC) were calculated using the formulae12:
CCZp

2Ddia DDþDD2
.
ð4DPÞ
DCZ

2Ddia DDþDD2
.
D2dia DP

CC is expressed in mm2 kPa1 and DC in 103 kPa1. Ddia
is the end-diastolic diameter (mm), DD is the diameter
change between diastole and systole (mm) and DP is the
brachial pulse pressure (kPa).
CC is the absolute change in cross-sectional area during
a cardiac cycle for a given increase in aortic pressure,
assuming that the length of the vessel is not affected by the
pulse wave. A decrease in CC indicates reduced vessel-
buffering capacity. DC is the relative change in aortic
diameter during a cardiac cycle for a given increase in
pressure and varies inversely with abdominal aortic
stiffness.
ACE and Abdominal aortic wall Mechanics 311There is a non-linear relationship between pressure and
diameter change in the abdominal aorta, the vessel being
very distensible at low pressures and small diameters and
becoming gradually stiffer (less compliant) with increasing
pressure and diameter.13 Stiffness b seems to be less
dependent on pressure changes,13 and may be used as
a complement to CC and DC. Stiffness b was calculated
according to13,14:
Stiffness bZln

Psys=Pdia
ðDD=DdiaÞ
Psys and Pdia represent the systolic and diastolic brachial
blood pressures in mmHg.
Blood pressure was measured in the brachial artery,
extrapolating this to the abdominal aorta, to calculate local
aortic stiffness, distensibility and compliance. There is
a good agreement between brachial and intra-arterial
aortic systolic pressure.15 The diastolic pressure is higher
in the brachial artery, leading to a slight systematic
underestimation of aortic stiffness.15 However, as no age-
or gender-related differences have been observed,15 this
systematic bias should not affect comparative studies
between groups or subjects.
ACE genotyping
Genomic DNA was isolated from peripheral blood using
QIAmp DNA Mini Kit (QIAGEN, Hilden, Germany) following
the manufacturer’s instructions. ACE genotype was deter-
mined using a previously described protocol.16
ACE assay
Plasma ACE levels were analysed using enzyme-linked
immunosorbent assay (ELISA) (Human ACE DuoSet, R&DTable 1 Characteristics of study population.
All
Number of subjects, n (%) 406
Age, years (SD) 78.8 (3.5)
Body mass index, kg/m2 (SD) 26.3 (3.8)
Plasma glucose, mmol/L (SD) 5.7 (2.2)
Plasma LDL, mmol/L (SD) 3.1 (1.0)
Plasma HDL, mmol/L (SD) 1.3 (0.3)
Blood pressure, mmHg (SD)
Systolic pressure 148 (23)
Diastolic pressure 75 (10)
Pulse pressure 73 (19)
Mean arterial pressure 103 (16)
History, n (%)
Ischaemic heart disease 89 (22)
Hypertension 337 (83)
Diabetes 87 (21)
Smoking 36 (9)
Values are mean (SD) or number of subjects (%).
P-values are men vs women.Systems, Minneapolis, MN, USA), following the manufac-
turer’s instructions. All samples were analysed in duplicate
and mean values were calculated. Duplicates where the
variance from the mean value exceeded 15% were
reanalysed.
Statistical analyses
The data are presented as mean values or number of
subjects. Men and women were analysed separately, as
abdominal aortic wall mechanics is known to be gender
dependent.17 Discrete variables were analysed using the c2
test. One-way analysis of variance (ANOVA) or Student’s
t-tests were used to compare continuous data between
groups, with adjustments for potentially confounding
factors. Multiple regression analyses were made to assess
the effect of ACE genotype and ACE level on CC, DC and
stiffness b, with adjustment for potentially confounding
factors. The HardyeWeinberg equilibrium was assessed by
c2 test. Values of p < 0.05 were considered statistically
significant. Statistical analyses were carried out using
Statistical Package for Social Sciences (SPSS) 17.0 for
Windows (SPSS Inc., Chicago, IL, USA).
Results
Study population
Characteristics of the study population are shown in Table
1. Nearly two-thirds (64%) of the study population was on
anti-hypertensive treatment (ACE inhibitor (ACEi) 20%,
angiotensin II receptor blockers 4%, beta blockers 36%,
calcium-channel blockers 18% and diuretics 36%) and 23%
was on statins (data not shown). There were no significantMen Women P
212 (52) 194 (48)
78.6 (3.1) 78.9 (3.8) 0.383
26.0 (3.2) 26.5 (4.3) 0.197
5.8 (2.0) 5.7 (2.4) 0.491
3.0 (0.8) 3.3 (1.1) <0.001
1.2 (0.3) 1.4 (0.4) <0.001
145 (22) 152 (24) 0.005
76 (10) 74 (11) 0.107
69 (18) 78 (20) <0.001
102 (15) 104 (17) 0.308
56 (26) 33 (17) 0.022
168 (79) 169 (87) 0.035
49 (23) 38 (20) 0.387
27 (13) 9 (5) 0.004
312 L.U. Ljungberg et al.differences in medications between men and women (data
not shown). Of the 429 subjects, 18 men (8%) and two
women (1%) were affected by AAA. Ten of the men were
excluded due to low quality of the ultrasonic measure-
ments, leaving eight men and two women with AAA in the
final study population of 406 subjects.ACEi treatment
Treatment with ACEi was associated with higher levels of
plasma ACE. Plasma ACE level was 308  112 ng ml1 in men
taking ACEi and 184  84 ng ml1 in men who were not
(p < 0.001). The corresponding ACE levels for women were
359  186 ng ml1 and 200  94 ng ml1 (p < 0.001). As ACEi
treatment induces up-regulation of ACE,18 subjects who
were on this treatment (43 men and 40 women) were
excluded from the statistical analyses of ACE levels.
Treatment with angiotensin II receptor blockers, beta
blockers, calcium-channel blockers, diuretics and statins
had no effect on plasma ACE (data not shown).Genotype frequency and association of ACE I/D
gene polymorphism with circulating ACE
The frequency of the D allele was 0.50 (men 0.48, women
0.53). The genotype frequencies were in accordance with
the HardyeWeinberg equilibrium. As shown in Fig. 1,
plasma ACE levels were influenced by ACE I/D poly-
morphism. The ACE D allele accounted for 17% (9% in men
and 27% in women) of the variance in plasma ACE level.
There was no difference in ACE level between men and
women (data not shown).Figure 1 Plasma ACE level (ng/ml) according to ACE I/D
polymorphism in men  and women ●. Individuals treated with
ACE inhibitors were excluded. ***p < 0.001.Association of ACE I/D polymorphism with
abdominal aortic wall mechanics
The characteristics of the study population according to
ACE I/D polymorphism are shown in Table 2 (men) and Table
3 (women). In men, there was a significant difference in
pulsatile diameter change (pZ 0.048) between genotypes,
and a tendency for DC (pZ 0.058). Using a dominant model
(II vs. ID/DD), men carrying the ACE D allele had lower
pulsatile diameter change (DDiaSys) (ID/DD 0.57 vs. II
0.70 mm, p Z 0.014) and DC (ID/DD 8.09 vs. II 10.38,
p Z 0.017) than subjects carrying the II genotype.
Excluding subjects with AAA had only little effect (DC
p Z 0.036). Using a recessive model (II/ID vs. DD), there
were no differences in abdominal aortic wall mechanics in
men (data not shown). In women, there was a difference in
age and frequency of IHD between genotypes, whereas
there was no difference in abdominal aortic wall
mechanics. In addition, more men with the II genotype
were on statins than men with the D allele (II 31% vs. ID/DD
17%, p Z 0.024) (data not shown). Subjects treated with
other cardiovascular drugs (ACEi, angiotensin II receptor
blockers, beta blockers, calcium-channel blockers and
diuretics) were evenly distributed between genotypes in
men and women (data not shown).Multiple regression analyses
Multiple regression analyses were used to further investi-
gate the association between ACE level, ACE genotype and
aortic wall properties in men (Table 4). The presence of the
D allele, circulating ACE level and potentially confounding
factors (age, MAP, BMI, heart rate, LDL, C-reactive protein,
diabetes mellitus, smoking and anti-hypertensive treat-
ment) were included. There was a significant association
between the presence of the D allele and reduced CC
(p Z 0.045), reduced DC (p Z 0.003) and increased stiff-
ness b (p Z 0.048), whereas no association was found with
ACE level. In addition, there was an association between
MAP and both CC and DC (p < 0.001) and an association
between BMI and CC, DC and stiffness b (p < 0.001).Discussion
In this study, we examined the impact of ACE I/D poly-
morphism and circulating ACE on abdominal aortic wall
mechanics. It is unknown whether the ACE I/D poly-
morphism acts in a dose-dependent, dominant or recessive
manner. Our results indicate that the association between
the ACE I/D polymorphism and abdominal aortic stiffness is
independent of one or two copies of the D allele, suggesting
a dominant pattern.
Men carrying the ACE D allele had lower pulsatile
diameter changes and lower DC in the abdominal aorta.
Multiple regression analyses showed additional associations
between the D allele and CC as well as stiffness b, sug-
gesting reduced buffering capacity as well as increased
stiffness. In line with our findings, Mattace-Raso et al.
found lower DC in ID and DD carriers compared with II,
whereas no difference was seen between ID and DD.19 In
Table 2 Characteristics according to ACE I/D polymorphism in men.
I/I I/D D/D P I/I ID/DD P
Number of subjects, n (%) 65 (31) 92 (43) 55 (26) 65 (31) 147 (69)
Age, years (SD) 78.6 (3.4) 77.9 (3.1) 77.9 (3.0) 0.351 78.6 (3.4) 77.9 (3.0) 0.147
Body mass index, kg/m2 (SD) 26.1 (3.6) 26.0 (3.2) 26.0 (3.0) 0.960 26.1 (3.6) 26.0 (3.1) 0.781
Laboratory data (SD)
Plasma glucose, mmol/L 6.1 (2.5) 5.8 (1.8) 5.5 (1.8) 0.243 6.1 (2.5) 5.7 (1.8) 0.191
Plasma LDL, mmol/L 2.8 (0.87) 3.0 (0.87) 3.0 (0.75) 0.398 2.8 (0.87) 3.0 (0.83) 0.179
Plasma HDL, mmol/L 1.2 (0.24) 1.2 (0.26) 1.3 (0.31) 0.065 1.2 (0.24) 1.2 (0.28) 0.322
Plasma ACE, ng/ml a 159 (85) 174 (76) 227 (80) <0.001 159 (85) 194 (81) 0.013
Blood pressure, mmHg (SD)
Systolic pressure 145 (23) 147 (22) 142 (20) 0.500 145 (23) 145 (22) 0.953
Diastolic pressure 75 (11) 78 (9) 73 (9) 0.041 75 (11) 76 (9) 0.471
Pulse pressure 70 (18) 69 (18) 69 (17) 0.887 70 (18) 69 (17) 0.636
Mean arterial pressure 102 (16) 104 (15) 100 (15) 0.421 102 (16) 102 (15) 0.707
Aortic wall properties (SD)
Intimaemedia thickness, mm 0.54 (0.11) 0.56 (0.15) 0.55 (0.15) 0.713 0.54 (0.11) 0.55 (0.15) 0.458
Diastolic lumen diameter, mm 17.0 (3.0) 17.8 (3.3) 17.4 (2.8) 0.347b 17.0 (3.0) 17.6 (3.1) 0.168b
Systolic lumen diameter, mm 17.7 (3.0) 18.3 (3.3) 18.0 (2.7) 0.533b 17.7 (3.0) 18.2 (3.1) 0.303b
Pulsatile diameter change, mm 0.70 (0.40) 0.55 (0.31) 0.60 (0.37) 0.048b 0.70 (0.40) 0.57 (0.34) 0.014b
Compliance coefficient, mm2/kPa 2.21 (1.60) 1.84 (1.3) 1.87 (1.24) 0.150c 2.21 (1.60) 1.85 (1.21) 0.061c
Distensibility coefficient, 103/kPa 10.38 (7.94) 7.68 (5.37) 8.79 (6.76) 0.058c 10.38 (7.94) 8.09 (5.93) 0.017c
Stiffness b 24.9 (20.4) 29.9 (19.2) 29.5 (21.9) 0.385d 24.9 (20.4) 29.7 (20.1) 0.129d
History, n (%)
Ischaemic heart disease 21 (32) 22 (24) 13 (24) 0.433 21 (32) 35 (24) 0.196
Hypertension 52 (80) 74 (80) 42 (76) 0.827 52 (80) 116 (79) 0.857
Diabetes 20 (31) 20 (22) 9 (16) 0.161 20 (31) 29 (20) 0.079
Smoking 10 (15) 7 (8) 10 (18) 0.132 10 (15) 17 (12) 0.442
Values are mean (SD) or number of subjects (%).
a Subjects treated with ACE inhibitors are excluded.
b Adjusted for age, MAP and BSA.
c Adjusted for age and MAP.
d Adjusted for age.
ACE and Abdominal aortic wall Mechanics 313addition, an association between the ACE D allele and
reduced CC has been reported.20
A number of studies have examined the link between
ACE I/D polymorphism and aortic stiffness determined by
carotidefemoral pulse wave velocity (PWV) measurements
(aortic PWV). Higher PWV has been reported in carriers of
the I allele,20e22 whereas others failed to identify any
associations.19 As PWV is measured between the carotid
and femoral arteries, it reflects the mean arterial stiffness
of several areas of the arterial tree. PWV may thus reflect
aspects of vascular function other than those measured in
our study. In addition, the elasticity of various arteries may
differ, and genetic determinants may produce different
outcomes depending on the artery studied.23
Although age is considered a major determinant of
arterial stiffness, our results did not show any association
between age and CC, DC or stiffness b. This is probably due
to the narrow age range in our study (70e88 years). In
younger subjects, there is a gender difference in abdominal
aortic stiffness, with men having stiffer aortas than women
of corresponding age.17 This study, however, did not findany gender-associated difference in abdominal aortic
stiffness. The calculated values of stiffness b were similar
to previous findings in elderly men,17 suggesting that age-
related changes in aortic wall properties accelerate in
women after menopause. Furthermore, in accordance with
previous data, BMI was shown to be a strong determinant of
CC, DC and stiffness b,24 and there was a positive associa-
tion between MAP and CC and DC, whereas stiffness b was
less dependent on MAP.13
The abdominal aorta is the most common site for
aneurysm formation.8 Most of the abdominal aortic media
lacks vasa vasorum and is instead supplied with oxygen and
nutrients by diffusion from the bloodstream.25 Increased
wall thickness, as a result of, for example, ageing may
therefore result in impaired nutrition of the abdominal
aortic wall. In addition, as a consequence of pulse-wave
reflections from the periphery, the abdominal aorta is
exposed to higher systolic and pulse pressures than other
central arteries.8 The mechanisms involved in aneurysm
formation are largely unknown; however, it has been
argued that a combination of local haemodynamic factors,
Table 3 Characteristics according to ACE I/D polymorphism in women.
I/I I/D D/D P I/I ID/DD P
Number of subjects, n (%) 46 (24) 89 (46) 59 (30) 46 (24) 148 (76)
Age, years (SD) 79.1 (3.8) 78.8 (3.7) 77.3 (3.7) 0.029 79.1 (3.8) 78.2 (3.8) 0.180
Body mass index, kg/m2 (SD) 26.2 (4.6) 26.0 (4.3) 27.6 (3.7) 0.072 26.2 (4.6) 26.6 (4.2) 0.522
Laboratory data (SD)
Plasma glucose, mmol/L 5.3 (1.2) 5.8 (2.7) 5.7 (2.8) 0.452 5.3 (1.2) 5.8 (2.7) 0.076
Plasma LDL, mmol/L 3.3 (0.95) 3.2 (1.15) 3.4 (1.0) 0.540 3.3 (0.95) 3.3 (1.11) 0.943
Plasma HDL, mmol/L 1.4 (0.45) 1.4 (0.34) 1.4 (0.35) 0.932 1.4 (0.45) 1.4 (0.35) 0.887
Plasma ACE, ng/mla 141 (55) 181 (69) 272 (105) <0.001 141 (55) 218 (96) <0.001
Blood pressure, mmHg (SD)
Systolic pressure 154 (26) 152 (24) 149 (24) 0.524 154 (26) 151 (24) 0.357
Diastolic pressure 76 (11) 74 (11) 73 (10) 0.525 76 (11) 74 (11) 0.282
Pulse pressure 79 (21) 78 (19) 76 (20) 0.700 79 (21) 77 (19) 0.575
Mean arterial pressure 107 (19) 103 (16) 103 (16) 0.335 107 (19) 103 (16) 0.141
Aortic wall properties (SD)
Intimaemedia thickness, mm 0.56 (0.15) 0.61 (0.25) 0.63 (0.2) 0.294 0.56 (0.15) 0.61 (0.22) 0.075
Diastolic lumen diameter, mm 14.4 (2.8) 14.6 (2.9) 15.1 (2.3) 0.437b 14.4 (2.8) 14.8 (2.6) 0.199b
Systolic lumen diameter, mm 14.9 (2.9) 15.2 (2.8) 15.7 (2.3) 0.427b 14.9 (2.9) 15.4 (2.6) 0.194b
Pulsatile diameter change, mm 0.55 (0.31) 0.61 (0.33) 0.58 (0.33) 0.943b 0.55 (0.31) 0.60 (0.33) 0.861b
Compliance coefficient mm2/kPa 1.38 (1.08) 1.44 (0.91) 1.50 (1.01) 0.921c 1.38 (1.08) 1.46 (0.95) 0.687c
Distensibility coefficient 103/kPa 8.24 (5.40) 9.29 (6.63) 8.60 (6.12) 0.708c 8.24 (5.40) 9.01 (6.41) 0.833c
Stiffness b 29.2 (23.0) 24.8 (16.7) 28.4 (30.0) 0.313d 29.2 (23.0) 26.3 (23.1) 0.633d
History, n (%)
Ischaemic heart disease 13 (28) 9 (10) 11 (19) 0.027 13 (28) 20 (14) 0.020
Hypertension 41 (89) 78 (88) 50 (85) 0.785 41 (89) 128 (86) 0.640
Diabetes 7 (15) 21 (24) 10 (17) 0.422 7 (15) 31 (21) 0.393
Smoking 2 (4) 3 (3) 4 (7) 0.624 2 (4) 7 (5) 1.00
Values are mean (SD) or number of subjects (%).
a Subjects treated with ACE inhibitors are excluded.
b Adjusted for age, MAP and BSA.
c Adjusted for age and MAP.
d Adjusted for age.
Table 4 Multiple regression analyses in men using compliance coefficient, distensibility coefficient and stiffness b as
dependent variables.
Compliance coefficient Distensibility coefficient Stiffness b
B SE of B P B SE of B P B SE of B P
Presence of D allele 0.48 0.238 0.045 3.55 1.163 0.003 7.50 3.76 0.048
ACE, ng/ml 0.001 0.001 0.691 0.01 0.006 0.308 0.02 0.02 0.329
Age, years 0.02 0.034 0.552 0.20 0.165 0.221 0.01 0.53 0.993
Map, mmHg 0.03 0.007 <0.001 0.14 0.034 <0.001 0.15 0.11 0.187
Body mass index, kg/m2 0.18 0.033 <0.001 0.79 0.163 <0.001 2.79 0.53 <0.001
Heart rate, beats/min 0.02 0.010 0.061 0.07 0.049 0.170 0.04 0.16 0.796
Plasma LDL, mmol/L 0.04 0.122 0.740 0.37 0.596 0.531 1.62 1.93 0.403
C-reactive protein, mg/L 0.001 0.006 0.819 0.02 0.030 0.588 0.03 0.10 0.802
Diabetes mellitus 0.20 0.290 0.492 1.94 1.416 0.173 0.01 4.58 0.998
Smoking 0.14 0.311 0.661 0.81 1.523 0.593 2.57 4.92 0.603
Antihypertensive medication 0.13 0.215 0.543 0.24 1.053 0.823 1.64 3.40 0.630
Adjusted r2 of the model 0.325 0.328 0.195
Subjects treated with ACE inhibitors are excluded.
B: regression coefficient, SE: Standard Error, Map: mean arterial pressure.
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ACE and Abdominal aortic wall Mechanics 315and factors affecting wall strength (genes, proteolytic
activity, inflammation, etc.) are of importance.8 We have
previously reported a relationship of aneurysm-associated
genetic variations on chromosome 9p21.3 with reduced
abdominal aortic stiffness,26 whereas this study showed
higher stiffness in carriers of the D allele. Deranged
abdominal aortic stiffness indicates impaired integrity of
the aortic wall, which might be important in aneurysmal
disease.27 As the ACE D allele is a common allele, it cannot
be the sole factor responsible. However, together with
other local factors, the ACE D allele may predispose to
aneurysm formation.
The prevalence of AAA in our population (8% in men and
1% in women) was similar to other populations.8 The low
prevalence of AAA made it impossible to explore the link
between the ACE I/D polymorphism and AAA. Such link has,
on the other hand, been identified by others.35
Previous experimental studies lend support to the
suggestion that ACE has a role in aneurysm formation.28,29
Accumulation of ACE has been reported in the abdominal
aortic wall in patients with aneurysm,28 and angiotensin II
infusion induces AAA in mice.29 It has been suggested
that the increased stiffness seen in carriers of the D allele
may be a consequence of exposure to higher levels of
ACE.19 Previous studies have shown that 20e50% of the
variation in ACE activity in the general population can
be explained by ACE I/D polymorphism.30,31 We,32 and
others31 have, however, shown large variations in ACE level
even between those carrying the same genotype; and only
17% of the variation in circulating ACE was related to ACE I/
D polymorphism in our elderly population. Interestingly,
although the ACE D allele was associated with increased
stiffness in the abdominal aorta in our study, we found no
link between circulating ACE and aortic stiffness (Table 3).
We do not yet know whether levels of circulating ACE
correlate with the levels in the arterial wall. Therefore,
although no connection between circulating ACE and aortic
stiffness was seen, we cannot rule out a possible link
between ACE level in the vessel wall and abdominal aortic
stiffness. The ACE D allele may be in linkage disequilibrium
with genetic variations in other genes, which, in turn, may
influence aortic stiffness. ACE I/D polymorphism may thus
represent a marker for another genetic polymorphism
involved in the regulation of vessel-wall mechanics.
This study provided evidence of an association between
the ACE D allele and aortic stiffness in men, whereas no
such association was found in women. This is interesting in
the context of aneurysm formation, as AAA is more common
in men.8 Previous studies investigating the link between the
ACE I/D polymorphism and arterial stiffness have analysed
mixed populations.19e21 The lack of association between
the ACE D allele and aortic stiffness in women may,
therefore, conceal the association in men, if mixed pop-
ulations are studied.Conclusions
This study shows an association between the ACE D allele
and abdominal aortic wall mechanics, with men carrying
the ACE D allele having a stiffer abdominal aorta than II
carriers. However, no association between circulating ACElevel and aortic stiffness was found, suggesting that the
effect of the D allele is due to factors other than elevated
levels of circulating ACE. Increased abdominal aortic stiff-
ness suggests impaired vessel-wall integrity, which,
combined with local haemodynamic, inflammatory as well
as other genetic factors, may have an important role in
aneurysm formation, and could possibly explain the previ-
ously reported association between the ACE I/D poly-
morphism and AAA.
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